Ovid Therapeutics
OVID
OVID
77 hedge funds and large institutions have $167M invested in Ovid Therapeutics in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 17 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
3% more capital invested
Capital invested by funds: $163M → $167M (+$4.17M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
77
Holding in Top 10
2
Calls
$8K
Puts
–
Top Buyers
| 1 | +$2.78M | |
| 2 | +$2.57M | |
| 3 | +$1.27M | |
| 4 |
Morgan Stanley
New York
|
+$724K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$324K |
Top Sellers
| 1 | -$418K | |
| 2 | -$146K | |
| 3 | -$95.4K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$62.3K |
| 5 |
JF
Jump Financial
Chicago,
Illinois
|
-$60.7K |